>
BRAIN Biotech AG logo

BNN - BRAIN Biotech AG Share Price

€10.25 0.9  9.5%

Last Trade - 14/05/21

Sector
Industrials
Size
Small Cap
Market Cap £175.3m
Enterprise Value £175.3m
Revenue £31.7m
Position in Universe 649th / 1053
Bullish
Bearish
Unlock BNN Revenue
Momentum
Relative Strength (%)
1m +16.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.65%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
23.9 25.0 26.4 29.1 40.0 39.1 41.7 47.5 +10.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 December 2020, BRAINBiotech AG revenues decreased 21% to EUR8.3M. Net lossincreased 49% to EUR3.4M. Revenues reflect Revenue decreaseof 22% to EUR8.1M. Higher net loss reflects Stock-basedCompensation in SGA increase from EUR79K to EUR160K(expense), Finance costs increase of 20% to EUR224K(expense), Depreciation and amortization and impairincrease of 4% to EUR905K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BNN Revenue Unlock BNN Revenue

Net Income

BNN Net Income Unlock BNN Revenue

Normalised EPS

BNN Normalised EPS Unlock BNN Revenue

PE Ratio Range

BNN PE Ratio Range Unlock BNN Revenue

Dividend Yield Range

BNN Dividend Yield Range Unlock BNN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BNN EPS Forecasts Unlock BNN Revenue
Profile Summary

BRAIN Biotech AG, formerly known as BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company develops and brings to market biological ingredients for Nutrition & Health, SkinCare and Industrial BioSolutions. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

Directors
Last Annual September 30th, 2020
Last Interim December 31st, 2020
Incorporated June 21, 2000
Public Since February 9, 2016
No. of Shareholders: n/a
No. of Employees: 283
Sector Industrials
Industry Professional & Commercial Services
Index Xetra Classic All Share , Xetra Prime All Share ,
Exchange XETRA
Shares in Issue 19,861,360
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BNN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BNN
Upcoming Events for BNN
Frequently Asked Questions for BRAIN Biotech AG
What is the BRAIN Biotech AG share price?

As of 14/05/21, shares in BRAIN Biotech AG are trading at €10.25, giving the company a market capitalisation of £175.3m. This share price information is delayed by 15 minutes.

How has the BRAIN Biotech AG share price performed this year?

Shares in BRAIN Biotech AG are currently trading at €10.25 and the price has moved by 15.17% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BRAIN Biotech AG price has moved by -12.22% over the past year.

What are the analyst and broker recommendations for BRAIN Biotech AG?

Of the analysts with advisory recommendations for BRAIN Biotech AG, there are there are currently 2 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for BRAIN Biotech AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will BRAIN Biotech AG next release its financial results?

BRAIN Biotech AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the BRAIN Biotech AG dividend yield?

BRAIN Biotech AG does not currently pay a dividend.

Does BRAIN Biotech AG pay a dividend?

BRAIN Biotech AG does not currently pay a dividend.

When does BRAIN Biotech AG next pay dividends?

BRAIN Biotech AG does not currently pay a dividend.

How do I buy BRAIN Biotech AG shares?

To buy shares in BRAIN Biotech AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BRAIN Biotech AG?

Shares in BRAIN Biotech AG are currently trading at €10.25, giving the company a market capitalisation of £175.3m.

Where are BRAIN Biotech AG shares listed? Where are BRAIN Biotech AG shares listed?

Here are the trading details for BRAIN Biotech AG:

Country of listing: Germany
Exchange: GER
Ticker Symbol: BNN
What kind of share is BRAIN Biotech AG?

Based on an overall assessment of its quality, value and momentum, BRAIN Biotech AG is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BRAIN Biotech AG share price forecast 2021?

Shares in BRAIN Biotech AG are currently priced at €10.25. At that level they are trading at 31.32% discount to the analyst consensus target price of 0.00.

Analysts covering BRAIN Biotech AG currently have a consensus Earnings Per Share (EPS) forecast of -0.348 for the next financial year.

How can I tell whether the BRAIN Biotech AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BRAIN Biotech AG. Over the past six months, the relative strength of its shares against the market has been 25.54%. At the current price of €10.25, shares in BRAIN Biotech AG are trading at 21.94% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BRAIN Biotech AG PE Ratio?

We were not able to find PE ratio data for BRAIN Biotech AG.

Who are the key directors of BRAIN Biotech AG?

BRAIN Biotech AG's management team is headed by:

Georg Kellinghusen - CSU
Ute Dechert - OTH
Michael Krohn - EVP
Martin Langer - EVP
Guido Meurer - EVP
Anna Eichhorn - VSU
Manfred Bender - CFO
Lukas Linnig - OTH
Alexander Pelzer - OTH
Adriaan Moelker - CMG
Bernhard Hauer - SUB
Michael Majerus - SUB
Who are the major shareholders of BRAIN Biotech AG?

Here are the top five shareholders of BRAIN Biotech AG based on the size of their shareholding:

Putsch (Martin) Individual Investor
Percentage owned: 36% (7.15m shares)
Founders and management of BRAIN Biotechnology Research and Corporation
Percentage owned: 9.6% (1.91m shares)
Hopp (Daniel) Individual Investor
Percentage owned: 6.6% (1.31m shares)
Lloyd Fonds AG Investment Advisor
Percentage owned: 4.3% (854k shares)
SPSW Capital GmbH Investment Advisor/Hedge Fund
Percentage owned: 4.18% (830k shares)
Similar to BNN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.